New Clinical Study Reveals Benefits of Masturbation for Menopause
A new clinical study led by Womanizer, a frontrunner in the field of women's sexual wellness, in collaboration with the Kinsey Institute at Indiana University, has unveiled some compelling evidence about the benefits of masturbation, particularly concerning menopause symptom relief. This study, unprecedented in its control and approach, has provided enlightening insights into the effects of self-pleasure on menopausal health and well-being.
Key Findings from the Study
The clinical research, which spanned from April to August 2025, engaged 66 women aged between 40 and 75, coming from 27 U.S. states and the District of Columbia. These women were not only peri-menopausal but also post-menopausal, ensuring a diverse representation of experiences and symptoms.
One of the most striking findings was that
92.9% of participants reported experiencing a reduction in at least one symptomatic manifestation of menopause after consistently using the Womanizer Next clitoral stimulator for just four weeks. The predominant improvements noted were in feeling more rested and experiencing fewer mood fluctuations. This highlights the potential for masturbation to play a critical role in symptom management.
Interestingly, a previous survey involving 1,500 American women noted that
36% found relief from menopause symptoms through masturbation, with about
10% relying on it as their primary strategy for relief. This forms the backdrop against which the current, more detailed study has been conducted.
Changing the Narrative on Menopause
Dr. Cynthia Graham from the Kinsey Institute stated, “Discussions around menopause tend to gravitate toward hormonal therapies or lifestyle alterations, while the topic of self-pleasure remains largely unaddressed.” The study's outcomes suggest that masturbation—particularly reaching orgasm—can significantly contribute to managing menopausal symptoms.
Furthermore, the participants conveyed a willingness to embrace masturbation as a method of symptom relief:
91% indicated they would be more inclined to engage in it if they were aware of its positive effects on menopause symptoms, while
79% expressed that they would heed a doctor's advice to do so. Yet, it’s concerning that only
3% had ever had a physician discuss masturbation with them.
The effectiveness of the Womanizer Next device itself also received notable reviews;
95% of women enjoyed using the product and
81.8% continued its use by the end of the study. Over a third reported that it facilitated achieving orgasm more easily as compared to their usual methods.
The Impact of Orgasm
The study revealed that while masturbation alone yielded benefits, the women who successfully reached orgasm experienced the most significant reductions in symptoms. This can likely be attributed to the neurochemicals released during orgasm, such as oxytocin and endorphins—known to enhance sleep quality, elevate mood, and alter pain perception favorably.
Importance of the Study
This research sheds light on a significant gap within patient care regarding menopause. While the interest in using masturbation for relief is high among participants, clinical recommendations seem to lag behind. By showcasing measurable benefits, both Womanizer and the Kinsey Institute hope to destigmatize self-pleasure and elevate sexual wellness as a critical aspect of menopause management.
Verena Singmann, Head of Public Relations at Womanizer stated,
“We’ve always recognized sexual wellness as essential to overall health, and this study reinforces how our products can support women through various life stages, especially menopause when pleasure is often sidelined.”
Sponsoring the study was Womanizer's Pleasure Fund, a five-year commitment of
$300,000 directed toward women's health research. This initiative aims to reduce the Gender Health Gap, ensuring that sexual wellness is understood as a vital component of health care.
For more details about this study and the implications of these findings, visit
Womanizer or learn more about the
Kinsey Institute.